Migraine Difficult to Treat: the Importance of Psychological Care in the Chronic Patient
Launched by UNIVERSITY OF VALENCIA · Dec 12, 2022
Trial Information
Current as of January 22, 2025
Completed
Keywords
ClinConnect Summary
Chronic diseases (CD) are characterized by their long duration, unpredictable changes in their course, in the person's appearance, limitations in physical capacity, prolonged dependence on medical specialists, continuous treatments and need for assistance.
Migraine is a neurological disorder characterized by episodic and recurrent attacks, which usually present with headache usually associated with hypersensitivity to external stimuli (visual, auditory, olfactory and cutaneous), nausea and vomiting. Migraine can be considered as a chronic process. Within this category, CM is diagnosed in p...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of chronic migraine difficult to treat for at least 6 months.
- • Be of legal age
- • Sign the informed consent form
- Exclusion Criteria:
- • Failure to meet the inclusion criteria
Trial Officials
Marián Pérez-Marín, PhD
Principal Investigator
Universitat de Valencia
About University Of Valencia
The University of Valencia, a prestigious institution located in Spain, is dedicated to advancing scientific knowledge and improving public health through innovative research. With a strong emphasis on interdisciplinary collaboration, the university engages in a wide array of clinical trials aimed at addressing pressing medical challenges. Its commitment to ethical standards and regulatory compliance ensures the integrity of its research initiatives, while its experienced team of researchers and clinicians work diligently to translate scientific discoveries into practical applications that benefit patients and communities. The University of Valencia is at the forefront of medical research, fostering a culture of excellence and innovation in the pursuit of better healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valencia, Comunitat Valenciana, Spain
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials